According to Tufts Center for the Study of Drug Development 11% of sites in a given trial typically fail to enroll a single patient, 37% under-enroll, 39% meet their enrollment targets, and 13% exceed their targets.
Medical Technologies was built to make study subject recruitment into clinical trials controlled and predictable.
Medical Technologies is a first dedicated network of clinical research units for early and late stage trials.
Medical Technologies is located in St. Petersburg, Russia.
The following clinical research sites work within Medical Technologies network:
- Medical Technologies
- Strategic Medical Systems
- «BioEq» (currently not working)
- Institute of Human Brain of the Russian Academy of Sciences
Medical Technologies focuses on bioequivalence, phase I-IV, confined/PK/PD studies utilizing healthy volunteers, special populations and patient population.
Breadth of our capabilities in clinical trials include:
- Phase I-IV in main therapeutic areas
- Phase I in patients
- Scientific research
- Different ways of administration/different dosage forms
- Drug, or alcohol interactions
- Bioequivalence studies
- Food influence (fasted/fed)
- Age/gender influence
- Special population studies
- Phase I in healthy volunteers
- Clamp clinical studies
Medical Technologies has necessary equipment and infrastructure to perform clinical trials in accordance with international standards.
Medical Technologies performs clinical trials in accordance with its medical license and clinical trials permit (accreditation).
Medical Technologies has a dedicated team of investigators, coordinators and nurses.
Medical Technologies staff has good understanding and experience in clinical trials in accordance with Good Clinical Practice.
Site medical staff is highly qualified. Our staff receives regular trainings at leading Russian and international medical institutions.
We have doctors specializing in different areas:
- Intensive care unit specialists
- Functional diagnostics specialists
- Clinical pharmacologists